nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—IL5—epithelium—rectum cancer	0.11	0.111	CbGeAlD
Pranlukast—MUC2—epithelium—rectum cancer	0.0846	0.0853	CbGeAlD
Pranlukast—MUC2—renal system—rectum cancer	0.0784	0.0791	CbGeAlD
Pranlukast—MUC2—female reproductive system—rectum cancer	0.0628	0.0633	CbGeAlD
Pranlukast—TNF—vagina—rectum cancer	0.0568	0.0573	CbGeAlD
Pranlukast—NFKB1—seminal vesicle—rectum cancer	0.0555	0.056	CbGeAlD
Pranlukast—IL5—lymph node—rectum cancer	0.0478	0.0482	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—rectum cancer	0.0456	0.046	CbGeAlD
Pranlukast—NFKB1—renal system—rectum cancer	0.0447	0.0451	CbGeAlD
Pranlukast—NFKB1—urethra—rectum cancer	0.0439	0.0443	CbGeAlD
Pranlukast—NFKB1—mammalian vulva—rectum cancer	0.0418	0.0422	CbGeAlD
Pranlukast—CYSLTR1—mammalian vulva—rectum cancer	0.0411	0.0414	CbGeAlD
Pranlukast—TNF—lymph node—rectum cancer	0.0368	0.0371	CbGeAlD
Pranlukast—NFKB1—female reproductive system—rectum cancer	0.0358	0.0361	CbGeAlD
Pranlukast—CYSLTR1—female reproductive system—rectum cancer	0.0352	0.0355	CbGeAlD
Pranlukast—NFKB1—vagina—rectum cancer	0.0324	0.0327	CbGeAlD
Pranlukast—CYSLTR1—vagina—rectum cancer	0.0318	0.0321	CbGeAlD
Pranlukast—NFKB1—lymph node—rectum cancer	0.021	0.0211	CbGeAlD
Pranlukast—CYSLTR1—lymph node—rectum cancer	0.0206	0.0208	CbGeAlD
Pranlukast—ABCC2—renal system—rectum cancer	0.0176	0.0177	CbGeAlD
Pranlukast—ABCC2—female reproductive system—rectum cancer	0.0141	0.0142	CbGeAlD
Pranlukast—CYP2C9—female reproductive system—rectum cancer	0.00937	0.00945	CbGeAlD
Pranlukast—CYP3A4—renal system—rectum cancer	0.00892	0.00899	CbGeAlD
Pranlukast—ABCC2—lymph node—rectum cancer	0.00823	0.00829	CbGeAlD
Pranlukast—CYP3A4—female reproductive system—rectum cancer	0.00714	0.0072	CbGeAlD
Pranlukast—IL5—Interleukin receptor SHC signaling—HRAS—rectum cancer	0.000348	0.0425	CbGpPWpGaD
Pranlukast—IL5—Interleukin-2 signaling—NRAS—rectum cancer	0.000314	0.0384	CbGpPWpGaD
Pranlukast—IL5—Interleukin-2 signaling—KRAS—rectum cancer	0.00027	0.0331	CbGpPWpGaD
Pranlukast—IL5—Interleukin-3, 5 and GM-CSF signaling—HRAS—rectum cancer	0.000242	0.0296	CbGpPWpGaD
Pranlukast—IL5—Interleukin-2 signaling—HRAS—rectum cancer	0.00023	0.0281	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—TP53—rectum cancer	0.000175	0.0214	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—ITGA2—rectum cancer	0.000167	0.0204	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—NRAS—rectum cancer	0.000161	0.0198	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—TP53—rectum cancer	0.000154	0.0188	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—KRAS—rectum cancer	0.000139	0.017	CbGpPWpGaD
Pranlukast—CYSLTR1—Endothelins—HRAS—rectum cancer	0.00013	0.016	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00013	0.0159	CbGpPWpGaD
Pranlukast—NFKB1—EPO signaling pathway—HRAS—rectum cancer	0.000127	0.0155	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—HRAS—rectum cancer	0.000118	0.0144	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.000112	0.0137	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	9.89e-05	0.0121	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	9.87e-05	0.0121	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	9.61e-05	0.0118	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	9.58e-05	0.0117	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	9.5e-05	0.0116	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—rectum cancer	8.81e-05	0.0108	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	8.51e-05	0.0104	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—KRAS—rectum cancer	8.47e-05	0.0104	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—HRAS—rectum cancer	8.35e-05	0.0102	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	8.27e-05	0.0101	CbGpPWpGaD
Pranlukast—NFKB1—Fc-epsilon receptor I signaling in mast cells—HRAS—rectum cancer	7.58e-05	0.00927	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—NRAS—rectum cancer	7.53e-05	0.00922	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—rectum cancer	7.53e-05	0.00922	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—NRAS—rectum cancer	7.45e-05	0.00912	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—rectum cancer	7.44e-05	0.0091	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—rectum cancer	7.41e-05	0.00907	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	7.35e-05	0.009	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	7.3e-05	0.00894	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—HRAS—rectum cancer	7.29e-05	0.00892	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	7.23e-05	0.00885	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—HRAS—rectum cancer	7.2e-05	0.00881	CbGpPWpGaD
Pranlukast—NFKB1—BCR signaling pathway—HRAS—rectum cancer	7.03e-05	0.0086	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	7.03e-05	0.0086	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ITGA2—rectum cancer	6.91e-05	0.00846	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	6.68e-05	0.00817	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—NRAS—rectum cancer	6.56e-05	0.00803	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—NRAS—rectum cancer	6.51e-05	0.00797	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—KRAS—rectum cancer	6.48e-05	0.00793	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—HRAS—rectum cancer	6.42e-05	0.00786	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—KRAS—rectum cancer	6.42e-05	0.00785	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—rectum cancer	6.38e-05	0.0078	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—HRAS—rectum cancer	6.36e-05	0.00779	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—rectum cancer	6.25e-05	0.00765	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—rectum cancer	6.13e-05	0.00751	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—rectum cancer	5.75e-05	0.00704	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	5.75e-05	0.00703	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—NRAS—rectum cancer	5.68e-05	0.00695	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—rectum cancer	5.67e-05	0.00694	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—KRAS—rectum cancer	5.64e-05	0.00691	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—KRAS—rectum cancer	5.6e-05	0.00686	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—HRAS—rectum cancer	5.55e-05	0.00679	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HRAS—rectum cancer	5.51e-05	0.00674	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—HRAS—rectum cancer	5.45e-05	0.00668	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—rectum cancer	5.42e-05	0.00663	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ITGA2—rectum cancer	5.27e-05	0.00645	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	5.23e-05	0.0064	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—rectum cancer	4.98e-05	0.00609	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—rectum cancer	4.91e-05	0.00601	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—KRAS—rectum cancer	4.89e-05	0.00598	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	4.88e-05	0.00598	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—HRAS—rectum cancer	4.8e-05	0.00587	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—HRAS—rectum cancer	4.76e-05	0.00583	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NRAS—rectum cancer	4.69e-05	0.00574	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—rectum cancer	4.67e-05	0.00572	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	4.63e-05	0.00566	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—NRAS—rectum cancer	4.6e-05	0.00564	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	4.42e-05	0.00541	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—KRAS—rectum cancer	4.32e-05	0.00528	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—rectum cancer	4.15e-05	0.00509	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—NRAS—rectum cancer	4.09e-05	0.005	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—KRAS—rectum cancer	4.04e-05	0.00494	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	3.98e-05	0.00487	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—KRAS—rectum cancer	3.96e-05	0.00485	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—rectum cancer	3.84e-05	0.0047	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—rectum cancer	3.81e-05	0.00466	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	3.8e-05	0.00465	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—rectum cancer	3.59e-05	0.00439	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	3.58e-05	0.00438	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—rectum cancer	3.56e-05	0.00436	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—rectum cancer	3.52e-05	0.00431	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KRAS—rectum cancer	3.52e-05	0.00431	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NRAS—rectum cancer	3.51e-05	0.00429	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—rectum cancer	3.43e-05	0.0042	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	3.38e-05	0.00414	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—rectum cancer	3.25e-05	0.00397	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	3.23e-05	0.00395	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	3.18e-05	0.00389	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—NRAS—rectum cancer	3.06e-05	0.00375	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—KRAS—rectum cancer	3.02e-05	0.0037	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRAS—rectum cancer	3.01e-05	0.00368	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—rectum cancer	2.99e-05	0.00366	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—rectum cancer	2.86e-05	0.0035	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	2.72e-05	0.00334	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NRAS—rectum cancer	2.69e-05	0.00329	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—rectum cancer	2.68e-05	0.00328	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—rectum cancer	2.63e-05	0.00322	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—rectum cancer	2.59e-05	0.00317	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRAS—rectum cancer	2.46e-05	0.00301	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—rectum cancer	2.45e-05	0.003	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	2.42e-05	0.00296	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—rectum cancer	2.32e-05	0.00284	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—rectum cancer	2.24e-05	0.00274	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—rectum cancer	2.2e-05	0.00269	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—rectum cancer	2.12e-05	0.00259	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—rectum cancer	1.97e-05	0.00241	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NRAS—rectum cancer	1.94e-05	0.00238	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NRAS—rectum cancer	1.93e-05	0.00236	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—rectum cancer	1.8e-05	0.0022	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRAS—rectum cancer	1.72e-05	0.0021	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—rectum cancer	1.67e-05	0.00205	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—rectum cancer	1.66e-05	0.00204	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRAS—rectum cancer	1.65e-05	0.00202	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRAS—rectum cancer	1.59e-05	0.00195	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NRAS—rectum cancer	1.48e-05	0.00181	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—rectum cancer	1.48e-05	0.00181	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—rectum cancer	1.42e-05	0.00174	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—rectum cancer	1.42e-05	0.00174	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—rectum cancer	1.41e-05	0.00173	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—rectum cancer	1.37e-05	0.00168	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—rectum cancer	1.27e-05	0.00156	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—rectum cancer	1.26e-05	0.00154	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—rectum cancer	1.22e-05	0.00149	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—rectum cancer	1.21e-05	0.00148	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—rectum cancer	1.16e-05	0.00142	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRAS—rectum cancer	1.14e-05	0.0014	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—rectum cancer	1.08e-05	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRAS—rectum cancer	9.99e-06	0.00122	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—rectum cancer	9.82e-06	0.0012	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—rectum cancer	8.73e-06	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—rectum cancer	8.6e-06	0.00105	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—rectum cancer	8.35e-06	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—rectum cancer	7.31e-06	0.000895	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRAS—rectum cancer	6.46e-06	0.000791	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—rectum cancer	5.56e-06	0.000681	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TYMS—rectum cancer	5.56e-06	0.000681	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—rectum cancer	4.94e-06	0.000605	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—rectum cancer	4.73e-06	0.000579	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TYMS—rectum cancer	3.67e-06	0.000449	CbGpPWpGaD
